Glenmark reaches 6 million Indians via its Hypertension Awareness Campaign

New Delhi: Glenmark Pharmaceuticals Limited (Glenmark) concluded its Hypertension Awareness Month campaign in May, partnering with over 1,000 healthcare professionals from more than 400 hospitals and clinics across 250 cities and towns in India.

This extensive initiative aimed to spread awareness about hypertension (high blood pressure) and its associated health risks.

Throughout the month, Glenmark organized over 400 public awareness rallies and blood pressure screening camps. These events featured informative sessions led by healthcare professionals, who provided detailed insights into the signs, symptoms, and preventive measures related to hypertension. Following these sessions, the screening camps offered the public an opportunity to assess their blood pressure levels. The campaign reached over 6 million adults through various channels, including Glenmark’s digital platform, www.bpincontrol.in.

Mr. Alok Malik, President & Head of India Formulations at Glenmark Pharmaceuticals Ltd., emphasized, “With the increasing prevalence of hypertension, it is crucial that we prioritize raising awareness about this silent killer among the Indian population, including young adults above the age of 18. Through our initiatives, we aim to empower individuals to take charge of their health by detecting hypertension early, as elevated blood pressure poses future cardiovascular risks. Together, we can make a significant difference in improving the health outcomes of millions affected by this condition.”

Glenmark has been proactive in raising hypertension awareness and promoting early diagnosis among the Indian population. The company launched the #TakeChargeAt18 campaign to drive hypertension awareness and screening among Indian adults over 18 years of age. Additionally, Glenmark introduced the world’s first-ever hypertension awareness symbol, “The BP logo,” in collaboration with the Hypertension Society of India (HSI) and the Association of Physicians of India (API) in 2020.

Hypertension is a prevalent cardiovascular disease (CVD) risk factor, affecting approximately 35.5% of adults in India. CVD is the leading cause of death in the country, responsible for nearly one-fourth of all mortality cases. India has set a goal of achieving a 25% relative reduction in the prevalence of high blood pressure among individuals aged 18 years and older by 2025. Achieving this goal requires a concerted effort to enhance awareness around hypertension, encouraging proactive management of the condition and the adoption of effective management strategies.